REFERENCES
- Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. Nebreda. 2000. Essential role of p38 alpha MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6: 109–116.
- Allen, M., L. Svensson, M. Roach, J. Hambor, J. McNeish, and C. A. Gabel. 2000. Deficiency of the stress kinase p38α results in embryonic lethality: characterization of kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191: 859–870.
- Bagrodia, S., B. Derijard, R. J. Davis, and R. A. Cerione. 1995. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270: 27995–27998.
- Beyaert, R., A. Cuenda, W. Vanden Berghe, S. Plaisance, J. C. Lee, G. Haegmann, P. Cohen, and W. Fiers. 1996. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15: 1914–1923.
- Blank, J. L., et al. 1996. Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase. J. Biol. Chem. 271: 5361–5368.
- Chadee, D., T. Yuasa, and J. M. Kyriakis. 2002. Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. Mol. Cell. Biol. 22: 737–749.
- Deacon, K., and J. L. Blanc. 1999. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. J. Biol. Chem. 274: 16604–16610.
- Derijard, B., J. Raingeaud, T. Barrett, L.-H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267: 682–685.
- Devin, A., A. Cook, Y. Lin, Y. Rodriguez, M. Kelliher, and Z. Liu. 2000. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12: 419–429.
- Dumitru, C. D., J. D. Ceci, C. Tsatsanis, D. Kontoyiannis, C. Patriotis, N. A. Jenkins, N. G. Copeland, G. Kollias, and P. Tsichlis. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071–1083.
- Ellinger-Zieglebauer, H., et al. 1997. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase ERK pathways by an inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272: 2668–2674.
- Feldmann, M., and R. N. Maini. 2001. Anti-TNF-α therapy of RA: what have we learned? Annu. Rev. Immunol. 19: 163–196.
- Garrington, T. P., and G. L. Johnson. 1999. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211–218.
- Han, J., Y. Jiang, Z. Li, V. V. Kravenchko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386: 296–299.
- Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor-1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495–504.
- Hsu, H., H. B. Shu, M. G. Pan, and D. V. Goeddel. 1996. TRAD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299–308.
- Hsu, H., J. Huang, H. B. Shu, V. Baichwal, and D. V. Goeddel. 1996. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor 1 signalling complex. Immunity 4: 387–396.
- Ichijo, H., E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, T. Moriguchi, M. Takagi, K. Matsumoto, K. Miyazono, and Y. Gotoh. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates the SAPK/JNK and p38 signaling pathways. Science 275: 90–94.
- Jiang, Y., H. Gram, M. Zhao, L. New, J. Gu, L. Feng, F. DiPadova, R. J. Ulevitch, and J. Han. 1997. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ. J. Biol. Chem. 272: 30122–30128.
- Jiang, Y., J. D. Woronicz, W. Liu, and D. V. Goeddel. 1999. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283: 543–546.
- Kelliher, M., S. Grimm, Y. Ishida, F. Kuo, B. Z. Stanger, and P. Leder. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8: 297–303.
- Kishimoto, K., K. Matsumoto, and J. Ninomiya-Tsuji. 2000. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J. Biol. Chem. 275: 7359–7364.
- Kotyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeler, H. D. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1: 94–99.
- Kruys, V., B. Beutler, and G. Huez. 1990. Translational control mediated by UA-rich sequences. Enzyme 44: 193–202.
- Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, T. F. Gallagher, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 327: 739–746.
- Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10: 2327–2334.
- Lin, Q., J. Schwarz, C. Bucana, and E. N. Olsen. 1997. Control of cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404–1407.
- Liu, Z., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565–576.
- Mudgett, J. S., J. Ding, L. Guh-Siesel, N. Chartrain, L. Yang, S. Gopal, and M. M. Shen. 2000. Essential role for p38-α mitogen-activated protein kinase in placental angiogenesis. Proc. Natl. Acad. Sci. USA 97: 10454–10459.
- Nguyen, T., G. S. Duncan, C. Mirtsos, M. Ng, D. E. Speiser, A. Shahinian, M. W. Marino, T. W. Mak, P. Ohashi, and W. C. Yeh. 1999. Traf 2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11: 379–389.
- Nihalani, D., S. Merritt, and L. B. Holzman. 2000. Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J. Biol. Chem. 275: 7273–7279.
- Price, M. A., F. Cruzalegui, and R. Treisman. 1996. The p38 and ERK MAP kinase pathways cooperate to activate ternary complex factors and c-fos transcription in response to UV light. EMBO J. 15: 6552–6563.
- Prichett, W., A. Hand, J. Sheilds, and D. Dunnington. 1995. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for tumor necrosis factor α. J. Inflamm. 45: 97–105.
- Raingeaud, J., S. Gupta, J. Rogers, M. Dickens, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause the p38 mitogen-activated kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270: 7420–7426.
- Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16: 1247–1255.
- Rouse, J. P. Cohen, S. Trigon, M. Morange, A. Alonso-Llamazares, D. Zamanillo, T. Hunt, and A. R. Nebreda. 1994. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78: 1027–1037.
- Salmeron, A., T. B. Ahmad, G. W. Carlile, D. Pappin, R. P. Narsimhan, and S. C. Ley. 1996. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15: 817–826.
- Shi, C.-S., A. Leonardi, J. Kyriakis, U. Siebenlist, and J. H. Kehrl. 1999. TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related. J. Immunol. 163: 3279–3285.
- Shimizu, H., K. Mitomo, T. Watanabe, S. Okamoto, and K. Yamamoto. 1990. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol. Cell. Biol. 10: 561–568.
- Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76: 959–962.
- Stanger, B. Z., P. Leder, T.-H. Lee, E. Kim, and B. Seed. 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 in yeast and causes cell death. Cell 81: 513–523.
- Stein, B., H. Brady, M. X. Yang, D. B. Young, and M. S. Barbosa. 1997. P38-2, a novel mitogen-activated protein kinase with distinct properties. J. Biol. Chem. 272: 19509–19517.
- Takekawa, M., F. Posas, and H. Saito. 1997. A human homologue of the yeast ssk2/ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways. EMBO J. 16: 4973–4982.
- Tamura, K., T. Sudo, U. Senftleben, A. M. Dadak, R. Johnson, and M. Karin. 2000. Requirement for p38α in erythropoietin expression: a role for stress kinases in erythropoiesis. Cell 102: 221–231.
- Tibbles, L. A., Y. L. Ing, F. Kiefer, J. Chan, N. Iscove, J. R. Woodgett, and N. J. Lassam. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15: 7026–7035.
- Ting, A. T., F. X. Pimentel-Muinos, and B. Seed. 1996. RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15: 6189–6196.
- Tong, L., S. Pav, D. M. White, S. Rogers, K. M. Crane, C. L. Cywin, M. L. Brown, and C. A. Pargellis. 1997. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4: 311–316.
- Vanden Berghe, W., S. Plaisance, E. Boone, K. De Bosscher, M. L. Schmitz, W. Fiers, and G. Haegemann. 1998. p38 and extracellular signal-related kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation. J. Biol. Chem. 273: 3285–3290.
- Wang, W., G. Zhou, M. C. T. Hu, Z. Yao, and T. H. Han. 1997. Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF-β signal transduction. J. Biol. Chem. 272: 22771–22775.
- Wang, X., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272: 1347–1349.
- Whitmarsh, A., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction. J. Mol. Med. 74: 589–607.
- Whitmarsh, A. J., S.-H. Yang, M. S.-S. Su, A. D. Sharrocks, and R. J. Davis. 1997. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17: 2360–2371.
- Wilson, K., P. G. McCaffrey, K. Hsiao, S. Pazhanisamy, V. Galullo, G. W. Blemis, M. J. Fitzgibbons, P. R. Caron, M. A. Murco, and M. S. Su. 1997. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Pyridinylimidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. Chem. Biol. 4: 423–431.
- Wysk, M., D. D. Yang, H. T. Lu, R. Flavell, and R. J. Davis. 1999. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. Proc. Natl. Acad. Sci. USA 96: 3763–3768.
- Xu, S., D. J. Robbins, L. B. Christerson, J. M. English, C. Vanderbilt, and M. H. Cobb. 1996. Cloning of rat MEK kinase 1 cDNA reveals an endogenous membrane-associated 195-kDa protein with a large regulatory domain. Proc. Natl. Acad. Sci. USA 93: 5291–5295.
- Yang, J., M. Boerm, M. McCarty, C. Bucana, I. Fidler, Y. Zhuang, and B. Su. 2000. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24: 309–313.
- Yang, J., Y. Lin, Z. Guo, J. Cheng, J. Huang, L. Deng, W. Liao, Z. Chen, Z. Liu, and B. Su. 2001. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat. Immunol. 2: 620–624.
- Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al. 1997. Early lethality, functional NF-κB activation and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715–725.
- Young, P. R., M. M. McLaughlin, S. Kumar, S. Kassis, M. L. Doyle, D. McNulty, T. F. Gallagher, S. Fisher, P. C. McDonnell, S. A. Carr, et al. 1997. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272: 12116–12121.
- Yuasa, T., S. Ohno, J. H. Kerl, and J. M. Kyriakis. 1998. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. J. Biol. Chem. 273: 22681–22692.
- Zechner, D., R. Craig, D. S. Hanford, P. M. McDonough, R. A. Sabbadini, and C. C. Glembotski. 1998. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273: 8232–8239.
- Zhang, Y., J.-X. Lin, and J. Vilèek. 1990. Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a κB-like sequence. Mol. Cell. Biol. 10: 3818–3823.
- Zhao, Q., and F. S. Lee. 1999. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β. J. Biol. Chem. 274: 8355–8358.